Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor
Authors
Keywords
-
Journal
OncoImmunology
Volume -, Issue -, Pages 1-19
Publisher
Informa UK Limited
Online
2018-06-13
DOI
10.1080/2162402x.2018.1470730
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
- (2018) Alexander D. Barrow et al. CELL
- Identification of Nidogen 1 as a lung metastasis protein through secretome analysis
- (2017) Maša Alečković et al. GENES & DEVELOPMENT
- NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells
- (2017) Ya Zhou et al. Oncotarget
- The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands
- (2017) Silvia Pesce et al. Frontiers in Immunology
- Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non–Small Cell Lung Cancer
- (2017) Nicholas Willumsen et al. NEOPLASIA
- Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity
- (2016) Christine Pasero et al. CANCER RESEARCH
- Immunological Mechanisms Underneath the Efficacy of Cancer Therapy
- (2016) L. Galluzzi et al. Cancer Immunology Research
- NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients
- (2016) Sylvie Rusakiewicz et al. OncoImmunology
- Increased Soluble CD155 in the Serum of Cancer Patients
- (2016) Akiko Iguchi-Manaka et al. PLoS One
- Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion
- (2015) Núria Pedrola et al. CLINICAL & EXPERIMENTAL METASTASIS
- Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis : A lesson from NKp44
- (2015) Michael Brusilovsky et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice
- (2015) Elisa Montaldo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Role of NK cells in immunotherapy and virotherapy of solid tumors
- (2015) Claudia Cantoni et al. Immunotherapy
- 2016 update of the PRIDE database and its related tools
- (2015) Juan Antonio Vizcaíno et al. NUCLEIC ACIDS RESEARCH
- Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients
- (2015) Michaela Semeraro et al. Science Translational Medicine
- NKG2D Receptor and Its Ligands in Host Defense
- (2015) L. L. Lanier Cancer Immunology Research
- B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
- (2015) Silvia Pesce et al. OncoImmunology
- Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30
- (2014) E. Schlecker et al. CANCER RESEARCH
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Nidogen-1: a candidate biomarker for ovarian serous cancer
- (2014) Lin Li et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack
- (2014) Wei Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells
- (2014) Nils A Kulak et al. NATURE METHODS
- Development of human natural killer cells and other innate lymphoid cells
- (2014) Elisa Montaldo et al. SEMINARS IN IMMUNOLOGY
- Clinical utility of natural killer cells in cancer therapy and transplantation
- (2014) David A. Knorr et al. SEMINARS IN IMMUNOLOGY
- Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
- (2014) Lorenzo Moretta et al. Frontiers in Immunology
- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
- (2013) Eric O. Long et al. Annual Review of Immunology
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- MYSM1 is mutated in a family with transient transfusion-dependent anemia, mild thrombocytopenia, and low NK- and B-cell counts
- (2013) A. Alsultan et al. BLOOD
- Identification of a cellular ligand for the natural cytotoxicity receptor NKp44
- (2013) F. Baychelier et al. BLOOD
- Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
- (2013) H. E. Kohrt et al. BLOOD
- Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity
- (2013) K. S. Reiners et al. BLOOD
- RORγt+ Innate Lymphoid Cells Acquire a Proinflammatory Program upon Engagement of the Activating Receptor NKp44
- (2013) Timor Glatzer et al. IMMUNITY
- Natural cytotoxicity receptors and their ligands
- (2013) Philip H Kruse et al. IMMUNOLOGY AND CELL BIOLOGY
- Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2
- (2013) Estefanía Martino-Echarri et al. INTERNATIONAL JOURNAL OF CANCER
- Immunobiology and Conflicting Roles of the Human NKG2D Lymphocyte Receptor and Its Ligands in Cancer
- (2013) A. El-Gazzar et al. JOURNAL OF IMMUNOLOGY
- Novel Interaction between Proliferating Cell Nuclear Antigen and HLA I on the Surface of Tumor Cells Inhibits NK Cell Function through NKp44
- (2013) Nathan C. Horton et al. PLoS One
- Epigenetic control of natural killer cell maturation by histone H2A deubiquitinase, MYSM1
- (2013) V. Nandakumar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activating natural cytotoxicity receptors of natural killer cells in cancer and infection
- (2013) Joachim Koch et al. TRENDS IN IMMUNOLOGY
- Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism
- (2012) F. B. Thoren et al. JOURNAL OF IMMUNOLOGY
- Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition
- (2011) E. Mamessier et al. CANCER RESEARCH
- Proliferating Cell Nuclear Antigen Is a Novel Inhibitory Ligand for the Natural Cytotoxicity Receptor NKp44
- (2011) B. Rosental et al. JOURNAL OF IMMUNOLOGY
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Basement membrane components are key players in specialized extracellular matrices
- (2010) Jenny Kruegel et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands
- (2010) Lola Fernández-Messina et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes
- (2010) F. Bellora et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New views on natural killer cell-based immunotherapy for melanoma treatment
- (2010) Shannon Burke et al. TRENDS IN IMMUNOLOGY
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Natural Cytotoxicity Receptors NKp30, NKp44 and NKp46 Bind to Different Heparan Sulfate/Heparin Sequences
- (2009) Marie-Lyn Hecht et al. JOURNAL OF PROTEOME RESEARCH
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells
- (2008) P. Vacca et al. INTERNATIONAL IMMUNOLOGY
- Nidogens—Extracellular matrix linker molecules
- (2008) Matthew S.P. HO et al. MICROSCOPY RESEARCH AND TECHNIQUE
- A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
- (2008) Marina Cella et al. NATURE
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
- Natural killer cell–directed therapies: moving from unexpected results to successful strategies
- (2008) Magali Terme et al. NATURE IMMUNOLOGY
- Dendritic Cells Release HLA-B-Associated Transcript-3 Positive Exosomes to Regulate Natural Killer Function
- (2008) Venkateswara Rao Simhadri et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now